期刊档案 · MEDICINE, GENERAL & INTERNAL
Current Issues in Pharmacy and Medical Sciences
ISSN 2084-980X · eISSN 2300-6676 · Sciendo · Poland
Current Issues in Pharmacy and Medical Sciences 中科院 医学 4区（2025 年升级版），影响因子 0.7（官网公布），完全开放获取，收取 APC，金额未公布，投稿社区反馈审稿约 16 周，2025 年发文 33 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Current Issues in Pharmacy and Medical Sciences 由 Sciendo 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Analytical Methods in Pharmaceuticals、Phytochemicals and Antioxidant Activities、Analytical Chemistry and Chromatography 等主题的论文，这 3 个主题约占 24.4%。（根据 OpenAlex 主题统计与中科院分区数据生成）
1. Aim and Scope Our mission is to advance scientific knowledge in pharmacy, medicine, dentistry, and health sciences through the publication of innovative, methodologically robust studies. To reflect the broad spectrum of biomedical research, the journal is organized into the following sections: Pharmaceutical Sciences – encompassing medicinal chemistry, pharmacology, pharmacognosy, pharmaceutical technology, biopharmacy, toxicology, and drug design. Medical Sciences – focusing on clinical and experimental medicine, translational research, diagnostics, and therapeutic strategies. Dentistry Sciences – dedicated to advances in dental materials, oral biology, clinical dentistry, maxillofacial research, and preventive oral health. Health Sciences – covering public health, epidemiology, health policy, nursing, physiotherapy, and medical education. Current Issues in Pharmacy and Medical Sciences welcomes original research articles, review papers, short communications, and case reports. We encourage submissions from both academic researchers and clinical practitioners, highlighting translational approaches that bridge experimental results and real-world medical applications. The journal supports the global exchange of scientific information and promotes open dialogue between scientists, clinicians, and healthcare professionals around the world. 2. Open Access Policy Current Issues in Pharmacy and Medical Sciences provides immediate open access to its content, supporting the principle that making research available to the public promotes a greater global exchange of knowledge.All articles published in the journal are freely available online without subscription or access fees. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of articles without asking prior permission from the publisher or the author, provided that the original work is properly cited. 3. Copyright and Licensing Authors retain the copyright to their work while granting the publisher the right to publish the article and identify itself as the original publisher.All articles in Current Issues in Pharmacy and Medical Sciences are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND 4.0). This license permits users to copy and redistribute the material in any medium or format for non-commercial purposes, provided that proper attribution is given to the original authors and the source, and the mat
摘自期刊官网 Aims & Scope
研究方向（LetPub）：MEDICINE, GENERAL & INTERNAL
主编 Mariola Herbet出版商官网
编委会国家分布：未见中国大陆编委；主要国家 波兰 12（共 12 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Analytical Methods in PharmaceuticalsChemistry9.4%
- Phytochemicals and Antioxidant ActivitiesMedicine8.1%
- Analytical Chemistry and ChromatographyChemistry6.9%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences5.8%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.6%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics5.1%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology4.8%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences3.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：内科MEDICINE, GENERAL & INTERNAL | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：内科MEDICINE, GENERAL & INTERNAL | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
Web of ScienceEmbase出版商官网
其他：Openalex、Library of Science、Sudoc、TitleDoi、Wikidata、Zdb、ICI Journals Master List
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 0.7出版商官网 ·
- CiteScore 2026-06
- 1.4LetPub ·
- CiteScore（出版商公布）
- 14出版商官网 ·
- SJR 2026-06
- 0.22LetPub ·
- SNIP 2026-06
- 0.33LetPub ·
- SNIP（出版商公布）
- 0.33出版商官网 ·
- h-index
- 17OpenAlex ·
- i10-index
- 59OpenAlex ·
- 两年平均被引
- 0.9OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 45LetPub ·
逐年发文量 OpenAlex 统计 · 累计 759 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 34 | 34 | 0 |
| 2025 | 33 | 33 | 18 |
| 2024 | 41 | 41 | 79 |
| 2023 | 41 | 41 | 91 |
| 2022 | 40 | 40 | 165 |
| 2021 | 42 | 42 | 128 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 16 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 16 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | PLN 600 / EUR 135 | 无 | CC BY | |
| OpenAlex | EUR 90 / PLN 369 | — | — | |
| LetPub | PLN 369 / EUR 90 | 无 | — | |
| 出版商官网 | EUR 135 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
官网政策摘录利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重
- 利益冲突 7. Conflicts of Interest
Authors must disclose any financial or personal relationships that could inappropriately influence their work. All sources of funding and potential conflicts of interest must be clearly stated in the manuscript. If no conflicts exist, authors should include the following statement in their manuscript: "The authors declare no conflict of interest."
原文 ↗出版商官网 ·- 数据可用性 9. Data Availability
Authors are encouraged to make the data supporting the results of their research publicly available whenever possible. Data may be deposited in appropriate public repositories or provided as supplementary materials accompanying the article.
原文 ↗出版商官网 ·- 出版伦理 5. Publication Ethics and Malpractice Statement
The journal is committed to maintaining the highest standards of integrity in scholarly publishing. The editorial policies follow internationally recognized ethical guidelines, including those provided by the Committee on Publication Ethics (COPE). Editors, reviewers, and authors are expected to adhere to ethical standards including:
原文 ↗出版商官网 ·- 许可与版权 3. Copyright and Licensing
Licensed under CC BY 4.0 (until May 22, 2026 CC-BY-NC-ND). 模型摘要
Authors retain the copyright to their work while granting the publisher the right to publish the article and identify itself as the original publisher.All articles in Current Issues in Pharmacy and Medical Sciences are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (CC BY-NC-ND 4.0). This license permits users to copy and redistribute the materi…
原文 ↗出版商官网 ·- 开放获取 2. Open Access Policy
Current Issues in Pharmacy and Medical Sciences provides immediate open access to its content, supporting the principle that making research available to the public promotes a greater global exchange of knowledge.All articles published in the journal are freely available online without subscription or access fees. Users are allowed to read, download, copy, distribute, print, search, or link to the…
原文 ↗出版商官网 ·- 同行评审 4. Peer Review Process
Peer-reviewed, open-access journal. 模型摘要
All submitted manuscripts undergo a rigorous peer review process. Following an initial editorial screening, manuscripts that meet the journal’s scope and basic quality requirements are sent to at least two independent reviewers who are experts in the relevant field. The journal applies a double-blind peer review process, in which both the reviewers and the authors remain anonymous throughout the r…
原文 ↗出版商官网 ·- 查重 6. Plagiarism and Similarity Check Policy
All submitted manuscripts are screened for plagiarism and text similarity using professional plagiarism detection software. Manuscripts that contain evidence of plagiarism, redundant publication, or significant overlap with previously published material will be rejected (above 30% Similarity Check). The editorial office reserves the right to request clarification or supporting documentation from a…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Sciendo
- 出版国家或地区
- Poland
- 出版语言
- English
- ISSN
- 2084-980X
- 电子版 ISSN
- 2300-6676
- 官网最新一期
- Volume 39, Issue 2（2026 年）
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Current Issues in Pharmacy and Medical Sciences 的常见问题
Current Issues in Pharmacy and Medical Sciences 是中科院几区期刊？
2025 年升级版分区表中，Current Issues in Pharmacy and Medical Sciences 为医学 4区，小类 医学：内科 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Current Issues in Pharmacy and Medical Sciences 的影响因子是多少？
期刊官网公布的影响因子为 0.7，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 1.4，h-index 为 17。
Current Issues in Pharmacy and Medical Sciences 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 16 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Current Issues in Pharmacy and Medical Sciences 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 12 位编委中，没有中国大陆学者；人数最多的国家是 波兰（12 位）。统计按编委会页面列出的机构国家计，仅供参考。
Current Issues in Pharmacy and Medical Sciences 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Current Issues in Pharmacy and Medical Sciences 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、Embase 收录，该清单未与各数据库逐一核对。
Current Issues in Pharmacy and Medical Sciences 是开放获取期刊吗？版面费多少？
Current Issues in Pharmacy and Medical Sciences 为完全开放获取。收取 APC，金额未公布。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。